Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Several Anti-Tumor Necrosis Factor alfa (TNF-alfa) antibodies / Tumor Necrosis Factor alfa (TNF-alfa) inhibitors are approved by both FDA and EMA for the treatment of moderate‑to‑severe Ulcerative colitis (UC) (1, 2).
Anti-Tumor Necrosis Factor alfa (TNF-alfa) antibodies / Tumor Necrosis Factor alfa (TNF-alfa) inhibitors are indicated for patients with moderate‑to‑severe Ulcerative colitis (UC) who have had an inadequate response, loss of response, or intolerance to conventional therapies such as 5-Aminosalicylic acid / Mesalazine, [corticosteroids](brain://Pg2Jd1_AB0W6iclZivqQ3Q…